<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Dosage & Monitoring - Pharmacology Quick Reference</title>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="styles/main.css">
</head>
<body>
    <a href="#main-content" class="skip-link">Skip to main content</a>
    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <div class="page-wrapper">
        <div class="container">
            <article class="document-article">
                <header class="document-header">
                    <div class="header-badge">
                        <span>üìê</span>
                        <span>Reference 02</span>
                    </div>
                    <h1 class="document-title">Dosage Regimens & Monitoring</h1>
                    <div class="title-meta">
                        <div class="meta-item">
                            <span>üìö</span>
                            <span>Standard Protocols & Therapeutic Windows</span>
                        </div>
                    </div>
                </header>

                <main id="main-content" class="content-wrapper">
                    <!-- Section 1: Malaria Dosing -->
                    <section class="content-section" id="malaria">
                        <div class="section-header">
                            <div class="section-number">01</div>
                            <h2 class="section-title">
                                <span class="title-icon">ü¶ü</span>
                                Malaria Treatment Protocols
                            </h2>
                        </div>
                        <div class="content-card">
                            <h3>Artemether-Lumefantrine (AL) Dosing</h3>
                            <p><strong>First Line for Uncomplicated Malaria.</strong> Dosing schedule: 0h, 8h, 24h, 36h, 48h, 60h (Total 6 doses).</p>
                            <div class="table-wrapper">
                                <div class="table-container">
                                    <table class="content-table">
                                        <thead>
                                            <tr>
                                                <th>Weight (kg)</th>
                                                <th>Age (Approx)</th>
                                                <th>Tablets per Dose</th>
                                                <th>Total Tabs</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td>5 - 14 kg</td>
                                                <td>5mo - 3 yrs</td>
                                                <td>1</td>
                                                <td>6</td>
                                            </tr>
                                            <tr>
                                                <td>15 - 24 kg</td>
                                                <td>3 - 7 yrs</td>
                                                <td>2</td>
                                                <td>12</td>
                                            </tr>
                                            <tr>
                                                <td>25 - 34 kg</td>
                                                <td>8 - 11 yrs</td>
                                                <td>3</td>
                                                <td>18</td>
                                            </tr>
                                            <tr>
                                                <td>> 34 kg</td>
                                                <td>> 12 yrs / Adult</td>
                                                <td>4</td>
                                                <td>24</td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>

                            <h3>Severe Malaria: Quinine Protocol</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <div class="list-marker">1</div>
                                    <div class="list-content">
                                        <strong>Loading Dose:</strong> 20 mg/kg body weight in 5% dextrose (run over 4 hours).
                                    </div>
                                </li>
                                <li class="list-item">
                                    <div class="list-marker">2</div>
                                    <div class="list-content">
                                        <strong>Maintenance Dose:</strong> 10 mg/kg body weight every 8 hours (starting 8 hours after loading dose).
                                    </div>
                                </li>
                                <li class="list-item">
                                    <div class="list-marker"></div>
                                    <div class="list-content">
                                        <em>Switch to oral medication as soon as patient can tolerate. Total treatment: 7 days.</em>
                                    </div>
                                </li>
                            </ul>
                        </div>
                    </section>

                    <!-- Section 2: Therapeutic Drug Monitoring -->
                    <section class="content-section" id="monitoring">
                        <div class="section-header">
                            <div class="section-number">02</div>
                            <h2 class="section-title">
                                <span class="title-icon">üìä</span>
                                Therapeutic Drug Monitoring
                            </h2>
                        </div>
                        <div class="content-card">
                            <p>Drugs with a <strong>Narrow Therapeutic Index</strong> require careful monitoring of serum levels to prevent toxicity.</p>
                            
                            <div class="table-wrapper">
                                <div class="table-container">
                                    <table class="content-table">
                                        <thead>
                                            <tr>
                                                <th>Drug</th>
                                                <th>Therapeutic Range</th>
                                                <th>Toxic Level</th>
                                                <th>Signs of Toxicity</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td><strong>Digoxin</strong></td>
                                                <td>0.5 ‚Äì 2.0 ng/mL</td>
                                                <td>> 2.0 ng/mL</td>
                                                <td>Halo vision, bradycardia, N/V</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Lithium</strong></td>
                                                <td>0.4 ‚Äì 1.0 mEq/L (Maint)<br>0.8 ‚Äì 1.4 mEq/L (Acute)</td>
                                                <td>> 1.5 mEq/L</td>
                                                <td>Tremors, polyuria, confusion</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Theophylline</strong></td>
                                                <td>10 ‚Äì 20 mcg/mL</td>
                                                <td>> 20 mcg/mL</td>
                                                <td>Tachycardia, seizures</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Phenytoin</strong></td>
                                                <td>10 ‚Äì 20 mcg/mL</td>
                                                <td>> 20 mcg/mL</td>
                                                <td>Nystagmus, ataxia, sedation</td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>
                        </div>
                    </section>

                    <!-- Section 3: Anticoagulant Monitoring -->
                    <section class="content-section" id="anticoagulants">
                        <div class="section-header">
                            <div class="section-number">03</div>
                            <h2 class="section-title">
                                <span class="title-icon">ü©∏</span>
                                Anticoagulant Monitoring
                            </h2>
                        </div>
                        <div class="content-card">
                            <h3>Warfarin (Coumadin)</h3>
                            <ul>
                                <li><strong>Test:</strong> PT / INR (Prothrombin Time / International Normalized Ratio)</li>
                                <li><strong>Normal INR:</strong> 1.0</li>
                                <li><strong>Therapeutic Goal:</strong> 2.0 ‚Äì 3.0 (for DVT/AFib)</li>
                                <li><strong>Antidote:</strong> Vitamin K</li>
                            </ul>

                            <h3>Heparin (Unfractionated)</h3>
                            <ul>
                                <li><strong>Test:</strong> aPTT (Activated Partial Thromboplastin Time)</li>
                                <li><strong>Therapeutic Goal:</strong> 1.5 ‚Äì 2.5 times the control value.</li>
                                <li><strong>Antidote:</strong> Protamine Sulfate</li>
                            </ul>
                        </div>
                    </section>
                </main>

                <nav class="document-nav">
                    <div class="nav-container">
                        <a href="reference-01-interactions.html" class="nav-button nav-button--large nav-button--previous">
                            <div class="nav-label">Previous</div>
                            <div class="nav-title">Drug Interactions</div>
                        </a>
                        <a href="index.html" class="nav-button nav-button--large nav-button--next">
                            <div class="nav-label">Finish</div>
                            <div class="nav-title">Back to Index</div>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>
    <script src="js/theme.js"></script>
</body>
</html>